AKT1 and non-small cell lung carcinoma: identified that CXCL5, a chemokine associated with NSCLC prognosis, is overexpressed in LC cells and to enhance LC progression through the activation of PI3K/AKT and MAPK/ERK1/2 signaling pathways (105).